.svg){kind=small}
Jun-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Aliviar has shown notable performance in the Tincture & Sublingual category within the state of Colorado. Over the past four months, the brand has consistently ranked within the top five, peaking at the second position in May 2024. This upward trend indicates a growing consumer preference for Aliviar's products in this category. However, a slight dip back to fourth place in June 2024 suggests that while the brand remains strong, it faces stiff competition. The sales figures support this performance, showing a steady increase from $30,784 in March to $37,673 in June, reflecting robust market acceptance and possibly effective sales strategies.
Despite Aliviar's impressive performance in Colorado, the absence of rankings in the top 30 for other states and categories highlights areas where the brand could improve its market penetration. This lack of presence outside of Colorado may suggest either a limited distribution network or a focus on strengthening their hold within a single state before expanding. For stakeholders and potential investors, this presents both a challenge and an opportunity: while the brand's current success is commendable, significant growth potential remains untapped in other regions and categories. Monitoring future movements and strategic expansions will be crucial for understanding Aliviar's long-term positioning in the broader cannabis market.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in Colorado, Aliviar has shown notable fluctuations in its rank and sales over recent months. Aliviar improved its position from 5th in March 2024 to 2nd in May 2024, before settling at 4th in June 2024. This upward trend in rank is mirrored by a consistent increase in sales, peaking at $37,673 in June 2024. In comparison, Escape Artists experienced a decline from 1st in April 2024 to 5th in June 2024, indicating potential market share loss. Meanwhile, My Brother's Flower has shown a strong performance, moving from 4th in March 2024 to 2nd in June 2024, with sales reaching $44,628. Care Division also demonstrated volatility, dropping to 6th in May 2024 but rebounding to 3rd in June 2024. Stratos maintained a relatively stable position, fluctuating between 5th and 6th place. These dynamics suggest that while Aliviar is gaining traction, it faces stiff competition from brands like My Brother's Flower and Escape Artists, necessitating strategic efforts to maintain and improve its market position.
Notable Products
The top product for Aliviar in June-2024 is the CBD/THC 20:1 Calm Tincture (1400mg CBD, 70mg THC) in the Tincture & Sublingual category, maintaining its consistent rank of 1st place with notable sales of 1076 units. The CBD/THC/CBN 5:1:1 Sleep Tincture (250mg CBD, 50mg THC, 50mg CBN, 10ml) also held its 2nd place position from previous months, although its sales dipped to 391 units. The CBD/THC 2:1 Scented Cream (420mg CBD, 210mg THC, 2oz) climbed back to 3rd place in June after briefly dropping to 4th place in May. The CBD/THC 2:1 Unscented Cream (650mg CBD, 325mg THC, 2oz) fell to 4th place in June from its 3rd place in May. A new entrant, the CBD/THC 2:1 Lavender Cream (650mg CBD / 325mg THC, 2oz), appeared in the rankings for the first time in June, securing the 5th position.
Top Selling Cannabis Brands
